This article describes the vocational experiences of college-educated individuals with visual impairments (VI). The participants were 16 college graduates and college students with VI, ages 19-55 years. The data were derived from qualitative research of phenomenological case studies and focused on six primary themes: (a) employers' lack of knowledge about VI (b) the need for self-advocacy, (c) benefits and limitations of working in companies with primarily VI populations, (d) lack of work experience, (e) barriers posed by inaccessible technology, and (f) barriers related to lack of transportation. The results indicated that improvements in the following areas are vital to increase the vocational success of college-educated individuals with VI: (a) employers' education about visual impairment, (b) improved self-advocacy skills, (c) higher levels of vocational experience, and (d) improved access to technology and transportation.
The study examined vocational rehabilitation outcomes of persons who were dually diagnosed with mental health and substance abuse disorders. The study sought to examine whether differences existed in vocational rehabilitation outcomes based upon the individuals' race by examining the 2002 RSA-911 database containing successful and unsuccessful closures (status 26 and 28). MANOVA and Chi-square analyses showed that minorities earned lower wages and received less college training than their non-minority counterparts. The results of the study indicated that statistically significant differences existed in vocational rehabilitation outcomes for individuals who are dually diagnosed, with minorities faring worse than their non-minority counterparts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.